Multicenter study of method-dependent epidemiological cutoff values for detection of resistance in candida spp. and aspergillus spp. to amphotericin B and echinocandins for the etest agar diffusion method

Maurizio Sanguinetti, Michael Lackner, A. Espinel-Ingroff, M. Arendrup, E. Canton, S. Cordob, E. Dannaoui, J. Garcia-Rodriguez, G. M. Gonzalez, N. P. Govender, E. Martin-Mazuelos, M. Lackner, C. Lass-Florl, M. J. Linares Sicilia, M. A. Rodriguez-Iglesias, T. Pelaez, R. K. Shields, G. Garcia-Effron, J. Guinea, J. Turnidger

Risultato della ricerca: Contributo in rivistaArticolo in rivista

30 Citazioni (Scopus)

Abstract

Method-dependent Etest epidemiological cutoff values (ECVs) are not available for susceptibility testing of either Candida or Aspergillus species with amphotericin B or echinocandins. In addition, reference caspofungin MICs for Candida spp. are unreliable. Candida and Aspergillus species wild-type (WT) Etest MIC distributions (microorganisms in a species-drug combination with no detectable phenotypic resistance) were established for 4,341 Candida albicans, 113 C. dubliniensis, 1,683 C. glabrata species complex (SC), 709 C. krusei, 767 C. parapsilosis SC, 796 C. tropicalis, 1,637 Aspergillus fumigatus SC, 238 A. flavus SC, 321 A. Niger SC, and 247 A. terreus SC isolates. Etest MICs from 15 laboratories (in Argentina, Europe, Mexico, South Africa, and the United States) were pooled to establish Etest ECVs. Anidulafungin, caspofungin, micafungin, and amphotericin B ECVs (in micrograms per milliliter) encompassing ≥97.5% of the statistically modeled population were 0.016, 0.5, 0.03, and 1 for C. albicans; 0.03, 1, 0.03, and 2 for C. glabrata SC; 0.06, 1, 0.25, and 4 for C. krusei; 8, 4, 2, and 2 for C. parapsilosis SC; and 0.03, 1, 0.12, and 2 for C. tropicalis. The amphotericin B ECV was 0.25 μg/ml for C. dubliniensis and 2, 8, 2, and 16 μg/ml for the complexes of A. fumigatus, A. flavus, A. Niger, and A. terreus, respectively. While anidulafungin Etest ECVs classified 92% of the Candida fks mutants evaluated as non-WT, the performance was lower for caspofungin (75%) and micafungin (84%) cutoffs. Finally, although anidulafungin (as an echinocandin surrogate susceptibility marker) and amphotericin B ECVs should identify Candida and Aspergillus isolates with reduced susceptibility to these agents using the Etest, these ECVs will not categorize a fungal isolate as susceptible or resistant, as breakpoints do.
Lingua originaleEnglish
pagine (da-a)1-11
Numero di pagine11
RivistaAntimicrobial Agents and Chemotherapy
Volume61
DOI
Stato di pubblicazionePubblicato - 2017

Keywords

  • Amphotericin B resistance
  • Antifungal resistance
  • ECVs
  • Echinocandin resistance
  • Etest ECVs
  • Etest MICs Aspergillus
  • Etest MICs Candida
  • Infectious Diseases
  • Non-WT
  • Pharmacology
  • Pharmacology (medical)
  • Susceptibility marker
  • WT isolates

Fingerprint Entra nei temi di ricerca di 'Multicenter study of method-dependent epidemiological cutoff values for detection of resistance in candida spp. and aspergillus spp. to amphotericin B and echinocandins for the etest agar diffusion method'. Insieme formano una fingerprint unica.

Cita questo